Expect higher prices, limited availability of materials in 2022

In a report outlining predictions for the coming year, the organization advises industry professionals to brace themselves for supply chain challenges.

Related Keywords

Manjit Singh ,Stephan Schmidinger ,Yasemin Bettina Karanis ,Tara Dougal ,European Union ,Chain Initiative ,Drug Administration ,Pharma Trends ,Pharmaceutical Supply Chain Initiative ,Bettina Karanis ,Markets Amp Regulations ,Ingredients ,Contract Manufacturing Amp Logistics ,Lobalization ,Covid 19 ,Excipients ,Raw Materials And Intermediates ,Processing Equipment ,Contract Manufacturing ,Regulatory Affairs ,Supply Chain ,Logistics ,Cphi Worldwide ,Predictive Analytics ,Manufacturing ,Drug Development ,Pi ,Xcipient ,